查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1613330

除热原无菌管瓶市场：按类型、容量和最终用户划分 - 全球预测 2025-2030

Depyrogenated Sterile Empty Vials Market by Type (Glass Vials, Plastic Vials), Capacity (10mL, 20mL, 2mL), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年Depyrogen无菌管瓶市值为7.9779亿美元，预计到2024年将达到8.4693亿美元，复合年增长率为6.67%，到2030年将达到12.5388亿美元。

除热原无菌管瓶市场在药品製造中发挥重要作用，其特点是为药品的储存和分配提供无热原容器。这些管瓶对于保持注射药物的完整性和确保患者安全至关重要。生技药品和疫苗产量的增加增加了生物技术和製药行业的需求，其应用范围包括药物製剂、冷冻干燥和注射剂的储存。最终使用领域包括医院、研发和製药公司，其中无菌管瓶支援药物开发和管理的各个阶段。关键的成长要素包括慢性病的增加、注射药物的强大管道、政府医疗保健支出的增加以及对患者安全和药物疗效的日益关注。新的发展机会在于开发采用改良材料的管瓶，以提高化学相容性，并更多地采用即用型预灌装系统，以简化操作并降低污染风险。然而，市场面临製造成本高、监管标准严格以及供应商必须应对的潜在供应链限制等挑战。市场相关人员应追求智慧包装的进步并整合物联网支援的功能来监控和确保即时品质保证。此外，使用环保和永续材料将有助于满足对环保解决方案不断增长的需求，使其成为创新的成熟领域。复杂的灭菌过程和监管合规障碍等逆境要求产业相关人员不断创新并适应技术和程序的变化。为了实现永续成长，相关人员应投资于专注于材料科学创新和自动化生产流程的研发，以满足精度、扩充性和合规性需求。整体而言，市场格局充满活力，成长潜力取决于策略性业务调整和技术投资。

主要市场统计
基准年[2023] 7.9779 亿美元
预计年份 [2024] 84693万美元
预测年份 [2030] 1,253,880,000 美元
复合年增长率（%） 6.67%

市场动态：快速发展的去热原无菌管瓶市场的关键市场洞察

供需的动态交互作用正在改变去热原无菌管瓶市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 製药和生物技术产业的需求不断增长
    • 政府机构和私人组织加强促进疫苗接种
  • 市场限制因素
    • 缺乏医疗基础设施
  • 市场机会
    • 灭菌和去热原技术的进步
    • 加强对无热原灭菌管瓶专用包装的关注
  • 市场挑战
    • 与仿冒品相关的风险

波特五力：驾驭去热原无菌管瓶市场的策略工具

波特的五力框架是了解去热源无菌管瓶市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解对去热原无菌管瓶市场的外部影响

外部宏观环境因素在塑造 Depyrogen 无菌管瓶市场的绩效动态方面发挥关键作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解去热原灭菌管瓶市场的竞争状况

对去热原灭菌管瓶市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵去热原无菌管瓶市场供应商的绩效评估

FPNV 定位矩阵是评估去热原无菌管瓶市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了去热源无菌管瓶市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对 Depyrogen 无菌管瓶市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 製药和生物技术产业的需求增加
      • 政府和私人组织正在加强促进疫苗接种。
    • 抑制因素
      • 缺乏医疗基础设施
    • 机会
      • 灭菌和去热原技术的进步
      • 更重视无热原灭菌管瓶的特殊包装
    • 任务
      • 与仿冒品相关的风险
  • 市场区隔分析
    • 类型：扩大使用具有成本效益的塑胶管瓶
    • 最终用户：在临床研究中增加使用去热原的无菌管瓶
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章去热原灭菌管瓶市场：依照类型

  • 管瓶
  • 塑胶管瓶

第七章去热原无菌管瓶市场：依容量

  • 10mL
  • 20mL
  • 2mL
  • 5mL

第八章去热原灭菌管瓶市场：依最终用户分类

  • 医疗机构
  • 製药公司
  • 研究/学术实验室

第九章北美和南美去热原管瓶市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太地区去热原无菌管瓶市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲的去热原无菌管瓶市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • ALK Life Science Solutions 与 Galenova 建立策略合作伙伴关係，销售除热原灭菌管瓶
    • 康宁与 SGD Pharma 就新玻璃管厂结成策略联盟
  • 战略分析和建议

公司名单

  • Arab Pharmaceutical Glass Co.（APG）
  • Bormioli Pharma
  • Consol Glass
  • Corning Inc.
  • Gerresheimer AG
  • Global Pharmatech Pvt. Ltd.
  • Hindusthan National Glass & Industries Ltd.
  • Nipro Corporation
  • Piramal Glass
  • SCHOTT AG
  • SGD Pharma
  • SGD SAS
  • Shandong Pharmaceutical Glass Co., Ltd.
  • Stevanato Group
  • Thermo Fisher Scientific Inc.
  • Triveni Polymers Pvt. Ltd.
  • West Pharmaceutical Services, Inc.
  • YPSOMED AG
Product Code: MRR-CB04E05659A7

The Depyrogenated Sterile Empty Vials Market was valued at USD 797.79 million in 2023, expected to reach USD 846.93 million in 2024, and is projected to grow at a CAGR of 6.67%, to USD 1,253.88 million by 2030.

The market for depyrogenated sterile empty vials is characterized by its critical role in pharmaceutical manufacturing, offering containers free from pyrogens for drug storage and distribution. These vials are essential in maintaining the integrity of injectable drugs, thus ensuring patient safety. With increasing demand in biotechnology and pharmaceutical industries, driven by the rise in biologics and vaccine production, the application scope encompasses drug compounding, lyophilization, and storage of injectable formulations. End-use sectors include hospitals, research labs, and pharmaceutical companies, where sterile vials support various stages of drug development and administration. Key growth influencers include rising incidences of chronic diseases, a robust pipeline of injectable drugs, escalating governmental health expenditure, and a heightened focus on patient safety and drug efficacy. Emerging opportunities lie in developing vials with improved materials for enhanced chemical compatibility and in the increasing adoption of ready-to-use and prefillable systems, which streamline operations and mitigate contamination risks. However, the market faces challenges such as high production costs, stringent regulatory standards, and potential supply chain constraints that suppliers must navigate. Market players should explore advancements in smart packaging and integrate IoT-enabled features to monitor and ensure real-time quality assurance. Moreover, utilizing eco-friendly and sustainable materials can cater to the growing demand for environmentally conscious solutions, presenting an area ripe for innovation. Adversities such as complex sterilization processes and regulatory compliance hurdles require industry players to innovate continually and adapt to technological and procedural changes. For sustained growth, stakeholders should invest in research and development focusing on material science innovations and automate production processes to meet precision, scalability, and compliance needs. Overall, the market exhibits a dynamic landscape ripe with potential for growth, contingent on strategic operational adaptations and technological investments.

KEY MARKET STATISTICS
Base Year [2023] USD 797.79 million
Estimated Year [2024] USD 846.93 million
Forecast Year [2030] USD 1,253.88 million
CAGR (%) 6.67%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Depyrogenated Sterile Empty Vials Market

The Depyrogenated Sterile Empty Vials Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increased demand from pharmaceutical and biotechnology industries
    • Growing initiatives from government and private organizations to advance vaccination
  • Market Restraints
    • Lack of healthcare infrastructure
  • Market Opportunities
    • Advancements in sterilization and depyrogenation technologies
    • Enhanced Focus on Specialized Packaging for depyrogenated sterile empty vials
  • Market Challenges
    • Risks associated with counterfeit products

Porter's Five Forces: A Strategic Tool for Navigating the Depyrogenated Sterile Empty Vials Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Depyrogenated Sterile Empty Vials Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Depyrogenated Sterile Empty Vials Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Depyrogenated Sterile Empty Vials Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Depyrogenated Sterile Empty Vials Market

A detailed market share analysis in the Depyrogenated Sterile Empty Vials Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Depyrogenated Sterile Empty Vials Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Depyrogenated Sterile Empty Vials Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Depyrogenated Sterile Empty Vials Market

A strategic analysis of the Depyrogenated Sterile Empty Vials Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Depyrogenated Sterile Empty Vials Market, highlighting leading vendors and their innovative profiles. These include Arab Pharmaceutical Glass Co. (APG), Bormioli Pharma, Consol Glass, Corning Inc., Gerresheimer AG, Global Pharmatech Pvt. Ltd., Hindusthan National Glass & Industries Ltd., Nipro Corporation, Piramal Glass, SCHOTT AG, SGD Pharma, SGD S.A.S, Shandong Pharmaceutical Glass Co., Ltd., Stevanato Group, Thermo Fisher Scientific Inc., Triveni Polymers Pvt. Ltd., West Pharmaceutical Services, Inc., and YPSOMED AG.

Market Segmentation & Coverage

This research report categorizes the Depyrogenated Sterile Empty Vials Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Glass Vials and Plastic Vials.
  • Based on Capacity, market is studied across 10mL, 20mL, 2mL, and 5mL.
  • Based on End-User, market is studied across Healthcare Institutions, Pharmaceutical Companies, and Research & Academic Labs.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased demand from pharmaceutical and biotechnology industries
      • 5.1.1.2. Growing initiatives from government and private organizations to advance vaccination
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of healthcare infrastructure
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in sterilization and depyrogenation technologies
      • 5.1.3.2. Enhanced Focus on Specialized Packaging for depyrogenated sterile empty vials
    • 5.1.4. Challenges
      • 5.1.4.1. Risks associated with counterfeit products
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Expanding use of plastic vials due to their cost effective nature
    • 5.2.2. End-user: proliferating use of depyrogenated sterile empty vials in clinical research
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Depyrogenated Sterile Empty Vials Market, by Type

  • 6.1. Introduction
  • 6.2. Glass Vials
  • 6.3. Plastic Vials

7. Depyrogenated Sterile Empty Vials Market, by Capacity

  • 7.1. Introduction
  • 7.2. 10mL
  • 7.3. 20mL
  • 7.4. 2mL
  • 7.5. 5mL

8. Depyrogenated Sterile Empty Vials Market, by End-User

  • 8.1. Introduction
  • 8.2. Healthcare Institutions
  • 8.3. Pharmaceutical Companies
  • 8.4. Research & Academic Labs

9. Americas Depyrogenated Sterile Empty Vials Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Depyrogenated Sterile Empty Vials Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Depyrogenated Sterile Empty Vials Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. ALK Life Science Solutions Forms Strategic Partnership with Galenova for Distribution of Depyrogenated Sterile Empty Vials
    • 12.3.2. Corning and SGD Pharma Forge Strategic Alliance with New Glass Tubing Facility
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Arab Pharmaceutical Glass Co. (APG)
  • 2. Bormioli Pharma
  • 3. Consol Glass
  • 4. Corning Inc.
  • 5. Gerresheimer AG
  • 6. Global Pharmatech Pvt. Ltd.
  • 7. Hindusthan National Glass & Industries Ltd.
  • 8. Nipro Corporation
  • 9. Piramal Glass
  • 10. SCHOTT AG
  • 11. SGD Pharma
  • 12. SGD S.A.S
  • 13. Shandong Pharmaceutical Glass Co., Ltd.
  • 14. Stevanato Group
  • 15. Thermo Fisher Scientific Inc.
  • 16. Triveni Polymers Pvt. Ltd.
  • 17. West Pharmaceutical Services, Inc.
  • 18. YPSOMED AG

LIST OF FIGURES

  • FIGURE 1. DEPYROGENATED STERILE EMPTY VIALS MARKET RESEARCH PROCESS
  • FIGURE 2. DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. DEPYROGENATED STERILE EMPTY VIALS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. DEPYROGENATED STERILE EMPTY VIALS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DEPYROGENATED STERILE EMPTY VIALS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DEPYROGENATED STERILE EMPTY VIALS MARKET DYNAMICS
  • TABLE 7. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY 10ML, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY 20ML, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY 2ML, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY 5ML, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HEALTHCARE INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH & ACADEMIC LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. DEPYROGENATED STERILE EMPTY VIALS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. DEPYROGENATED STERILE EMPTY VIALS MARKET, FPNV POSITIONING MATRIX, 2023